JCO Article Insights: Pooled Taletrectinib Efficacy and Safety

<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">In this JCO Article Insights episode, host Peter Li summarizes "<a href="https://ascopubs.org/doi/10.1200/JCO-25-00275" target= "_blank" rel="noopener">Taletrectinib in ROS1-Mutated Non–Small Cell Lung Cancer: TRUST</a>" by Pérol et al, published April 03, 2025, followed by an interview with first author, Dr Maurice Pérol.</span></p> <p><span style= "text-decoration: underline; font-size: 12pt; font-family: arial, helvetica, sans-serif;"> <strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal" style= "text-align: center; margin: 12.0pt 0in 12.0pt 0in;" align= "center"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><em style="mso-bidi-font-style: normal;"> <span lang="EN" xml:lang="EN">The disclosures for guests on this podcast can be found in the show notes.</span></em></span></p> <p class="MsoNormal" style="margin: 10.0pt 0in 10.0pt 0in;"> <span style= "font-size: 12pt; font-f...